Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer

BACKGROUND: Utilization of alternative transcription start sites through alterations in epigenetic promoter regions causes reduced expression of immunogenic N-terminal peptides, which may facilitate immune evasion in early gastric cancer. We hypothesized that tumors with high alternate promoter util...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Oncol
Autors principals: Sundar, R, Huang, K K, Qamra, A, Kim, K -M, Kim, S T, Kang, W K, Tan, A L K, Lee, J, Tan, P
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442650/
https://ncbi.nlm.nih.gov/pubmed/30624548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy550
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars